| Role of the p53-homologue p73 in E2F1-induced apoptosis T Stiewe, BM Pützer Nature genetics 26 (4), 464-469, 2000 | 429 | 2000 |
| The p53 family in differentiation and tumorigenesis T Stiewe Nature Reviews Cancer 7 (3), 165-167, 2007 | 340 | 2007 |
| Transactivation-deficient ΔTA-p73 inhibits p53 by direct competition for DNA binding implications for tumorigenesis T Stiewe, CC Theseling, BM Pützer Journal of Biological Chemistry 277 (16), 14177-14185, 2002 | 240 | 2002 |
| Transactivation-deficient ΔTA-p73 acts as an oncogene T Stiewe, S Zimmermann, A Frilling, H Esche, BM Pützer Cancer research 62 (13), 3598-3602, 2002 | 237 | 2002 |
| Gene expression changes in response to E2F1 activation J Stanelle, T Stiewe, CC Theseling, M Peter, BM Pützer Nucleic acids research 30 (8), 1859-1867, 2002 | 199 | 2002 |
| Role of p73 in malignancy: tumor suppressor or oncogene? T Stiewe, BM Pützer Cell Death & Differentiation 9 (3), 237-245, 2002 | 187 | 2002 |
| A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism A Pribluda, E Elyada, Z Wiener, H Hamza, RE Goldstein, M Biton, ... Cancer cell 24 (2), 242-256, 2013 | 149 | 2013 |
| Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells M Michaelis, F Rothweiler, S Barth, J Cinatl, M Van Rikxoort, ... Cell death & disease 2 (12), e243-e243, 2011 | 137 | 2011 |
| p53 family members in myogenic differentiation and rhabdomyosarcoma development H Cam, H Griesmann, M Beitzinger, L Hofmann, R Beinoraviciute-Kellner, ... Cancer cell 10 (4), 281-293, 2006 | 133 | 2006 |
| Quantitative TP73 transcript analysis in hepatocellular carcinomas T Stiewe, S Tuve, M Peter, A Tannapfel, AH Elmaagacli, BM Pützer Clinical cancer research 10 (2), 626-633, 2004 | 114 | 2004 |
| Immune and inflammatory cell composition of human lung cancer stroma GA Banat, A Tretyn, SS Pullamsetti, J Wilhelm, A Weigert, C Olesch, ... PLOS one 10 (9), e0139073, 2015 | 87 | 2015 |
| p73 in apoptosis T Stiewe, BM Pützer Apoptosis 6 (6), 447-452, 2001 | 81 | 2001 |
| DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis K Schlereth, R Beinoraviciute-Kellner, MK Zeitlinger, AC Bretz, M Sauer, ... Molecular cell 38 (3), 356-368, 2010 | 80 | 2010 |
| KINK-1, a novel small-molecule inhibitor of IKKβ, and the susceptibility of melanoma cells to antitumoral treatment M Schön, BG Wienrich, S Kneitz, H Sennefelder, K Amschler, V Vöhringer, ... Journal of the National Cancer Institute 100 (12), 862-875, 2008 | 74 | 2008 |
| E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products BM Pützer, T Stiewe, K Parssanedjad, S Rega, H Esche Cell death & Differentiation 7 (2), 177-188, 2000 | 73 | 2000 |
| Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7. 1 genes BM Pützer, T Stiewe, F Rödicker, O Schildgen, S Rühm, O Dirsch, ... Journal of the National Cancer Institute 93 (6), 472-479, 2001 | 72 | 2001 |
| p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo O Timofeev, K Schlereth, M Wanzel, A Braun, B Nieswandt, ... Cell reports 3 (5), 1512-1525, 2013 | 71 | 2013 |
| Characterization of the p53 cistrome–DNA binding cooperativity dissects p53's tumor suppressor functions K Schlereth, C Heyl, AM Krampitz, M Mernberger, F Finkernagel, ... PLoS Genet 9 (8), e1003726, 2013 | 70 | 2013 |
| p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth M Beitzinger, L Hofmann, C Oswald, R Beinoraviciute‐Kellner, M Sauer, ... The EMBO journal 27 (5), 792-803, 2008 | 69 | 2008 |
| Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction F Rödicker, T Stiewe, S Zimmermann, BM Pützer Cancer research 61 (19), 7052-7055, 2001 | 64 | 2001 |
